Moving genomics from the bench to the bedside

by on

The FDA’s recent de novo authorization of the first and only whole exome sequencing platform has the potential to accelerate the integration of genomics into clinical care.

The FDA’s recent de novo authorization of the first and only whole exome sequencing platform has the potential to accelerate the integration of genomics into clinical care.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: